Miacalcin and Teveten drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Miacalcin (calcitonin, salmon) and Teveten (eprosartan mesylate). Common drug interactions include depression among females and dysphasia among males.

The phase IV clinical study analyzes what interactions people have when they take Miacalcin and Teveten. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Miacalcin?

Miacalcin has active ingredients of calcitonin, salmon. It is often used in osteoporosis. eHealthMe is studying from 5,437 Miacalcin users. Check the latest studies of Miacalcin.

What is Teveten?

Teveten has active ingredients of eprosartan mesylate. It is often used in high blood pressure. eHealthMe is studying from 1,482 Teveten users. Check the latest studies of Teveten.

On Jul, 29, 2026

21 people who take Miacalcin and Teveten together, and have interactions are studied.

Miacalcin and Teveten drug interactions.

What are the common drug interactions of Miacalcin and Teveten, by gender? *:

female:

Depression
Diarrhoea
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Erb's palsy (nerve injury that effects the movement of a child's shoulder, arm, and hand)
Facial bones fracture (bone fracture of face)
Fall
Fatigue (feeling of tiredness)
Gastrinoma (a tumour in the pancreas or duodenum that secretes excess of gastrin leading to ulceration)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Injury

male:

Dysphasia (language disorder marked by deficiency in the generation of speech)
Hemiparesis (weakness on one side of the body)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

What are the common drug interactions of Miacalcin and Teveten, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dysphasia (language disorder marked by deficiency in the generation of speech)
Hemiparesis (weakness on one side of the body)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

60+:

Abscess oral (abscess in the mouth)
Adenoma benign (non-cancerous tumour -secreting)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiomegaly (increased size of heart than normal)
Chest pain
Cholecystitis (infection of gallbladder)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Choroidal detachment (separation of vascular layer of the eye)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Compression fracture (fracture due to pressure caused by injury)

What are the existing conditions these people have? *

Pain: 17 people, 80.95%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 17 people, 80.95%
Depression: 17 people, 80.95%

* Approximation only. Some reports may have incomplete information.

Do you take Miacalcin and Teveten?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously